Houston Methodist. Leading Medicine.
Houston Methodist. Leading Medicine

Methodist J.C. Walter Jr. Transplant Center - Houston, TX

Dr. Carlos M. Orrego

Total: 25 projects

  1. Project Name: The Role of Copper in Congestive Heart Failure – Carlos M. Orrego
    Location: Houston Methodist Hospital
    Principal Investigator: – Carlos M. Orrego, M.D.
    Dates: 2007 – 2009

  2. Project Name: Immune characterization in Acute Decompensated Heart Failure – Carlos M. Orrego
    Location: Houston Methodist Hospital
    Principal Investigator: Guillermo Torre-Amione, M.D., Ph.D.
    Dates: 2006- 2008

  3. Project Name: Evaluation of Ischemic Burden in Patients with Acute Heart Failure – Carlos M. Orrego
    Location: Houston Methodist Hospital
    Principal Investigator: Guillermo Torre-Amione, M.D., Ph.D.
    Dates: 2006- 2008

  4. Project Name: Study of Myocardial Structure and Function in Patients with End stage Heart Failure in Need of Mechanical Circulatory Support – Carlos M. Orrego
    Location: Houston Methodist Hospital
    Principal Investigator: Guillermo Torre-Amione, M.D., Ph.D.
    Dates: 2006- 2008

  5. Project Name: Effect of Plasma Exchange on Patients with Chronic Refractory Heart Failure – Carlos M. Orrego
    Location: Houston Methodist Hospital
    Principal Investigator: Guillermo Torre-Amione, M.D, Ph.D.
    Dates: 2004- 2008

  6. Project Name: ARISTOTLE – Carlos M. Orrego
    Location: Houston Methodist Hospital
    Principal Investigator: Multi-center study
    Dates: 2007- 2008

  7. Project Name: ASCEND HF – Carlos M. Orrego
    Location: Multi-center study/ Houston Methodist Hospital
    Principal Investigator: Robert Califf, M.D.
    Dates: 2007- 2008

  8. Project Name: CHAMPION HF – Carlos M. Orrego
    Location: Multi-center study/ Houston Methodist Hospital
    Principal Investigator: Philip Adamson, M.D., FACC / William T. Abraham, M.D., FACP, FACC
    Dates: 2004- 2008

  9. Project Name: MOMENTUM – Carlos M. Orrego
    Location: Houston Methodist Hospital
    Principal Investigator: Multi-center study
    Dates:

  10. Project Name: REACH UP – Carlos M. Orrego
    Location: Houston Methodist Hospital
    Principal Investigator: Multi-center study
    Dates: 2004- 2008

  11. Project Name: CHRONICLE ICD – Carlos M. Orrego
    Location: Houston Methodist Hospital
    Principal Investigator: Multicenter
    Dates: 2004- 2008

  12. Project Name: CRST – Carlos M. Orrego
    Location: Houston Methodist Hospital
    Principal Investigator: Guillermo Torre-Amione, M.D, Ph.D.
    Dates: 2006- 2008

  13. Project Name: Genetic Influences On LV Recovery Recent Onset Cardiomyopathy (IMAC-Ii) – Carlos M. Orrego
    Location: Houston Methodist Hospital
    Principal Investigator: Guillermo Torre-Amione, M.D, Ph.D.
    Dates: 2007- 2008

  14. Project Name: A Prospective, Randomized, Double-Blind, Double-Dummy, Parallel-Group, Multicenter, Event-Driven, Non-inferiority Study Comparing the Efficacy and Safety of Once-Daily Oral Rivaroxaban (BAY 59-7939) With Adjusted-Dose Oral Warfarin for the Prevention of Stroke and Non-Central Nervous System Systemic Embolism in Subjects with Non-Valvular Atrial Fibrillation (ROCKET-HF) – Carlos M. Orrego
    Location: Houston Methodist Hospital
    Principal Investigator: Multi-center study
    Dates: 2007- 2008

  15. Project Name: Evaluation of the VentrAssist™ Left Ventricular Assist Device as a Bridge to Cardiac Transplantation-Pivotal Trial – Carlos M. Orrego
    Location: Houston Methodist Hospital
    Principal Investigator: Multi-center study
    Dates: 2008- 2009

  16. Project Name: Evaluation of the VentrAssist® Left Ventricular Assist Device for the Treatment of Advanced Heart Failure – Destination Therapy – Carlos M. Orrego
    Location: Houston Methodist Hospital
    Principal Investigator: Multi-center study
    Dates: 2008- 2009

  17. Project Name: 24-month, multi-center, randomized, open-label non-inferiority study of efficacy and safety comparing two exposures of concentration-controlled Certican with reduced Neoral versus 3.0 g MMF with standard dose Neoral in de novo heart transplant recipients. – Carlos M. Orrego
    Location: Houston Methodist Hospital
    Principal Investigator: Multi-center study
    Dates: 2007- 2008

  18. Project Name: Transplant-Eligible Patient Management for Congestive Heart Failure (TMAC) Pulmonary Function Testing Substudy (A051-B0)(Amendment 2 dated March 3, 2006) - Substudy to IRB0606-0089 – Carlos M. Orrego
    Location: Houston Methodist Hospital
    Principal Investigator: Guillermo Torre-Amione, M.D, Ph.D.
    Dates: 2008- 2009

  19. Project Name: Transplant-Eligible Patient Management for Congestive Heart Failure (TMAC) Glomerular Filtration Rate Substudy (Amendment 2 dated March 3, 2006) - Substudy to IRB0606-0089 – Carlos M. Orrego
    Location: Houston Methodist Hospital
    Principal Investigator: Guillermo Torre-Amione, M.D, Ph.D.
    Dates: 2008- 2009

  20. Project Name: Transplant-Eligible Patient Management for Congestive Heart Failure (TMAC) with Continuous Infusion of Nesiritide or Placebo – Carlos M. Orrego
    Location: Houston Methodist Hospital
    Principal Investigator: Guillermo Torre-Amione, M.D, Ph.D.
    Dates: 2008- 2009

  21. Project Name: A phase 2b, Double-Blind, Double Dummy, Randomized, Parallel Group Study to evaluate the Safety and Efficacy of Twice Daily Dosing and once Daily Dosing of YM150 in Subjects Undergoing Primary Elective Knee Arthroplasty – Carlos M. Orrego
    Principal Investigator:
    Dates: 2008 – 2009

  22. Project Name: RED-HF trial – Carlos M. Orrego
    Principal Investigator: Guillermo Torre-Amione, M.D., Ph.D.
    Dates: 2006 – 2009

  23. Project Name: 2CRAD - 4 Month, Multicenter, Randomized, Open-Label Non-Inferiority Study of Efficacy and Safety Comparing Two Exposures of Concentration-Controlled Certican With Reduced Neoral Versus 3.0g MMF With Standard Dose Neoral In De Novo Heart Transplant Recipients – Carlos M. Orrego
    Location: Houston Methodist Hospital
    Principal Investigator: Guillermo Torre-Amione, M.D, Ph.D.
    Dates: 2007 – 2009

  24. Project Name: DDAT - Clinical Implications of Diastolic Dysfunction Among Heart Transplantation Recipients Emphasizing the Importance of Aldosterone Antagonism
    Location: Houston Methodist Hospital – Carlos M. Orrego
    Principal Investigator: Guillermo Torre-Amione, M.D, Ph.D.
    Dates: 2007 – 2009

  25. Project Name: Heart-Liver Transplant Immune Tolerance – Carlos M. Orrego
    Location: Houston Methodist Hospital
    Principal Investigator: Guillermo Torre-Amione, M.D, Ph.D.
    Dates: 2007 – 2009